10:00 à 10:20
Colloque

Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling

Session 1

Andrew Lane
Premier symposium international THEMA Saint-Louis sur la leucémie
10:00 à 10:20
    Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot
    En libre accès, dans la limite des places disponibles
    -

    Intervenant(s)

    Andrew Lane

    Événements

    Opening speech
    Hugues de Thé, Lise Alter & Matthieu Resche-Rigon

    Colloque
    09:00 à 09:30
    Non enregistré

    Therapy Response and Resistance of AML Stem Cells to Venetoclax
    Andreas Trumpp

    Colloque
    09:30 à 09:50

    Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
    Andrew Lane

    Colloque
    10:00 à 10:20

    Overcoming Therapy Resistance in Acute Myeloid Leukemia
    Alexandre Puissant

    Colloque
    10:30 à 10:50

    Regulation of Hematopoietic Stem Cell Dormancy
    Nina Cabezas

    Colloque
    11:10 à 11:40

    Unmasking Myeloproliferative Neoplasms Transformation Paths
    Lina Benajiba

    Colloque
    11:40 à 12:00

    AML State-Switched
    Clemens Schmitt

    Colloque
    12:05 à 12:30
    Non enregistré

    Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML 
    Marc Raaijmakers

    Colloque
    14:30 à 14:55

    Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia
    Diana Passaro

    Colloque
    14:55 à 15:20
    Non enregistré

    Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
    David Michonneau

    Colloque
    15:20 à 15:40

    Words from patients
    Emmanuel Raffoux

    Colloque
    16:00 à 16:20

    AML Therapy in 2024: increasingly individualized approaches
    Courtney DiNardo

    Colloque
    16:20 à 16:45

    VEXAS Syndrome in 2024
    Olivier Kosmider

    Colloque
    16:45 à 17:05

    Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
    Régis Peffault de Latour

    Colloque
    17:05 à 17:30

    Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
    Lars Velten

    Colloque
    09:00 à 09:25

    Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
    Emmanuelle Clappier

    Colloque
    09:25 à 09:50

    From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
    Guillaume Andrieu

    Colloque
    09:50 à 10:15

    Developmental Origins of Childhood Leukemia: why does it matter?
    Anindita Roy

    Colloque
    10:15 à 10:40

    AML: Lessons from the Genome
    Timothy Ley

    Colloque
    11:00 à 11:25
    Non enregistré

    Targeting Evil Enhancers and Genes in AML
    Ruud Delwel

    Colloque
    11:25 à 11:50

    Targeting Cystine Import in AML
    Raphael Itzykson

    Colloque
    11:50 à 12:20

    Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
    Keisuke Ito

    Colloque
    13:50 à 14:15

    Targeting Microenvironmental Drivers of Blood Malignancies
    Bethan Psaila

    Colloque
    14:15 à 14:40
    Non enregistré

    Any Crosstalk in the Treatment of AML and HR-MDS
    Lionel Adès

    Colloque
    14:40 à 15:10

    Clonal Evolution of Genetic Predisposition to Hematological Malignancies
    Marie Sebert

    Colloque
    15:30 à 15:50

    PML Unravels New Insights into the Bases of AML Chemotherapy Response
    Domitille Rérolle

    Colloque
    15:50 à 16:15

    Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation
    Paresh Vyas

    Colloque
    16:15 à 16:40

    Voir aussi

    Hugues de Thé, chaire Oncologie cellulaire et moléculaire
    Premier symposium international THEMA Saint-Louis sur la leucémie